The pharmaceutical landscape is witnessing a change with the introduction of GLP-1 transdermal systems . These exciting formulations offer a possible alternative to administering glucagon-like peptide-1 https://arranvgmg826944.techionblog.com/41186178/glp-1-patches-a-novel-way-to-treat-blood-sugar